National Key R&D Program of China(2020YFC0860900);Emergency Key Program of Guangzhou Laboratory(EKPG21-30-4).
Background Whether methylprednisolone therapy can reduce the mortality rate of patients with severe coronavirus disease 2019(COVID-19)remains controversial,and its effects on the length of hospital stay and virus shed...
supported by grants from the National Key R&D Program of China(2020YFC0860900);the Emergency Key Program of Guangzhou Laboratory(EKPG21-30-4).
Background:The benefits and harms of methylprednisolone treatment in patients with moderate coronavirus disease 2019(COVID-19)remain controversial.In this study,we investigated the effect of methylprednisolone on mort...
Objective To investigate whether high-dose methylprednisolone with Rituximab and fresh frozen plasma(HDMP+RTX+FFP)is an effective therapy for patients with B-cell chronic lymphoproliferative disorders(B-CLPD)with TP53...
supported by National Natural Sciences Foundation of China(No.81501552,and No.81401388)
The clinical application of orbital magnetic resonance(MR) T2-mapping imaging in detecting the disease activity of Graves' ophthalmopathy(GO), and the predictive values of therapy response to intravenous glucocor...
ACKNOWLEDGEMENTS This study is supported by the National Natural Science Foundation of China (Nos. 30801039 and 81072424) and the major projects of viral hepatitis from Beijing Municipal Science and Technology Commission (No. H020920020890). We thank the volunteers who generously participated in this study.
Acute-on-chronic liver failure (ACLF) is a severe life-threatening complication. Liver transplantation is the only available therapeutic option; however, several limitations have restricted its use in patients. The ...
BACKGROUND: For the treatment of spinal cord injury, any pathological changes of the injured tissue should be primarily corrected or reversed. Any remaining fibrous function and neurons with intact structure should b...